Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Seq of the aorta of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

ABSTRACT: RNA-Seq of the aorta of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

PROVIDER: PRJEB32990 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR3367690_1.fastq.gz	Fastqsanger.gz
	ERR3367690_2.fastq.gz	Fastqsanger.gz
	ERR3367691_1.fastq.gz	Fastqsanger.gz
	ERR3367691_2.fastq.gz	Fastqsanger.gz
	ERR3367692_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

RNA-Seq of the aorta of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

Project description:We fed hypercholesterolemic mice high fat diet containing either ticagrelor, clopidogrel, or nothing (control) for 16 weeks, isolated the aortae, extracted RNA, and subjected the RNA to RNA-Seq using NGS.

2019-06-16 | E-MTAB-8050 | biostudies-arrayexpress

RNA-Seq of the liver of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

Project description:We fed hypercholesterolemic mice high fat diet containing either ticagrelor, clopidogrel, or nothing (control) for 16 weeks, isolated the liver, extracted RNA, and subjected the RNA to RNA-Seq using NGS.

2019-06-16 | E-MTAB-8049 | biostudies-arrayexpress

RNA-Seq of the liver of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

Project description:RNA-Seq of the liver of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

| PRJEB32991 | ENA

E-MTAB-8050

Project description:RNA-Seq of the aorta of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

2019-08-08 | E-MTAB-8050 | ExpressionAtlas

Red-fleshed apples rich in anthocyanins and white-fleshed apples poor in anthocyanins modulate aorta and heart proteome in hypercholesterolemic rats. The AppleCOR study

Project description:New mechanisms-of-action of anthocyanins (ACNs) provided by a red-fleshed apple compared with a white-fleshed apple ACN-poor, and with an ACN-rich extract on the proteome profile of aorta and heart as cardiovascular key tissues were determined. Hypercholesterolemic Wistar rats were separated into the corresponding groups to analyze the proteomic profile of the aorta and heart tissues using nano-liquid chromatography coupled to mass-spectrometry. Red-fleshed apple downregulated CRP, C1QB and CFP related-inflammation. White-fleshed apple reduced C1QB, CFB, CFD, C3, and C9 related to the complement system, reduced MB and CP related to iron metabolism, and increased ME1, PKM, and PC related to energy homeostasis. ACN-rich extract increased FMOD, TAGLN, and CAP1 related to cellular structure and decreased PRKACA, IQGAP1, and HSP90AB1 related to cellular signaling. Red-fleshed apple rich in ACNs suggested an anti-inflammatory effect while white-fleshed apple reduced the complement system protein-related. An apple matrix effect reduced inflammatory proteins regardless their ACN content.

2022-04-04 | PXD018885 | Pride

Microarray gene expression profiling of aorta genes of APOE-deficient mice receiving the ACE inhibitor captopril

2009-12-03 | GSE19286 | GEO

Transcription profiling of mouse aorta genes of APOE-deficient animals receiving the ACE inhibitor captopril

Project description:Microarray gene expression profiling of aorta genes of APOE-deficient mice receiving atherosclerosis treatment with the ACE inhibitor captopril. Hypercholesterolemic APOE-deficient mice were used as a standard model of atherosclerosis to study gene expression changes during atherosclerosis treatment with the ACE inhibitor captopril. Microarray analysis was performed of whole aortas isolated from captopril-treated APOE-deficient mice relative to untreated APOE-deficient mice with overt atherosclerosis, and nontransgenic control mice. Microarray gene expression profiling revealed that captopril-mediated atherosclerosis prevention involved inhibition of aorta-infiltrating immune cells such as pro-atherogenic T lymphocytes and macrophages. Experiment Overall Design: Microarray gene expression profiling was performed of whole aortas isolated from APOE-deficient mice with atherosclerosis relative to captopril-treated APOE-deficient mice, and nontransgenic control mice. Three study groups were analyzed, i.e. 8-months-old untreated APOE-deficient mice with overt atherosclerosis, age-matched APOE-deficient mice treated for 7 months with the angiotensin-converting enzyme (ACE) inhibitor, captopril (20 mg/kg in drinking water), and nontransgenic control C57BL/6J mice. Two biological replicates were made of each group, and total RNA of three aortas was pooled for one gene chip.

2009-12-14 | E-GEOD-19286 | biostudies-arrayexpress

E-MTAB-8049

Project description:RNA-Seq of the liver of hypercholesterolemic mice treated by either ticagrelor, clopidogrel, or control.

2019-08-08 | E-MTAB-8049 | ExpressionAtlas

Celecoxib, Rofecoxib Gavage Treated Mice, Aorta RNA-Seq

Project description:Celecoxib, Rofecoxib Gavage Treated Mice, Aorta RNA-Seq

2020-03-07 | GSE97066 | GEO

Celecoxib, Rofecoxib Chronically Treated Mice, Aorta RNA-Seq

Project description:Celecoxib, Rofecoxib Chronically Treated Mice, Aorta RNA-Seq

2020-03-07 | GSE95802 | GEO